Portal de Periódicos da CAPES

Response by Pérez de Isla et al to Letter Regarding Article, “Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients With Familial Hypercholesterolemia: The ARCHITECT Study”

2023; Lippincott Williams & Wilkins; Volume: 148; Issue: 13 Linguagem: Inglês

10.1161/circulationaha.123.066276

1524-4539

Leopoldo Pérez de Isla, Adriana Saltijeral Cerezo, Pedro Mata,

Atherosclerosis and Cardiovascular Diseases

HomeCirculationVol. 148, No. 13Response by Pérez de Isla et al to Letter Regarding Article, "Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients With Familial Hypercholesterolemia: The ARCHITECT Study" No AccessLetterRequest AccessFull TextAboutView Full TextView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toNo AccessLetterRequest AccessFull TextResponse by Pérez de Isla et al to Letter Regarding Article, "Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients With Familial Hypercholesterolemia: The ARCHITECT Study" Leopoldo Pérez de Isla, Adriana Saltijeral Cerezo and Pedro Mata Leopoldo Pérez de IslaLeopoldo Pérez de Isla https://orcid.org/0000-0002-9706-7783 Cardiology Department, Clinico San Carlos University Hospital, Madrid, Spain (L.P.d.I.). , Adriana Saltijeral CerezoAdriana Saltijeral Cerezo Cardiology Department, Hospital Vithas Aravaca, Madrid, Spain (A.S.C.). and Pedro MataPedro Mata Fundación Hipercolesterolemia Familiar, Madrid, Spain (P.M.). Originally published25 Sep 2023https://doi.org/10.1161/CIRCULATIONAHA.123.066276Circulation. 2023;148:1059–1060"Response by Pérez de Isla et al to Letter Regarding Article, "Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients With Familial Hypercholesterolemia: The ARCHITECT Study"." Circulation, 148(13), pp. 1059–1060FootnotesCirculation is available at www.ahajournals.org/journal/circREFERENCES1. De Graaf MA, Broersen A, Kitslaar PH, Roos CJ, Dijkstra J, Lelieveldt BPF, Jukema JW, Schalij MJ, Delgado V, Bax JJ, et al. Automatic quantification and characterization of coronary atherosclerosis with computed tomography coronary angiography: cross-correlation with intravascular ultrasound virtual histology.Int J Cardiovasc Imaging. 2013; 29:1177–1190. doi: 10.1007/s10554-013-0194-xCrossrefMedlineGoogle Scholar2. Papadopoulou SL, Garcia-Garcia HM, Rossi A, Girasis C, Dharampal AS, Kitslaar PH, Krestin GP, De Feyter PJ. Reproducibility of computed tomography angiography data analysis using semiautomated plaque quantification software: implications for the design of longitudinal studies.Int J Cardiovasc Imaging. 2013; 29:1095–1104. doi: 10.1007/s10554-012-0167-5CrossrefMedlineGoogle Scholar3. Perez De Isla L, Diaz-Diaz JL, Romero MJ, Muniz-Grijalvo O, Mediavilla JD, Argueso R, Sanchez Munoz-Torrero JF, Rubio P, Alvarez-Banos P, Ponte P, et al. Alirocumab and coronary atherosclerosis in asymptomatic patients with familial hypercholesterolemia: the ARCHITECT study.Circulation. 2023; 147:1436–1443. doi: 10.1161/CIRCULATIONAHA.122.062557LinkGoogle Scholar4. Pérez De Isla L, Alonso R, Mata N, Fernández-Pérez C, Muñiz O, Díaz-Díaz JL, Saltijeral A, Fuentes-Jiménez F, De Andrés R, Zambón D, et al. Predicting cardiovascular events in familial hypercholesterolemia: the SAFEHEART registry (Spanish Familial Hypercholesterolemia Cohort Study).Circulation. 2017; 135:2133–2144. doi: 10.1161/CIRCULATIONAHA.116.024541LinkGoogle Scholar5. Bourbon M, Alves AC, Alonso R, Mata N, Aguiar P, Padró T, Mata P. Mutational analysis and genotype-phenotype relation in familial hypercholesterolemia: the SAFEHEART registry.Atherosclerosis. 2017; 262:8–13. doi: 10.1016/j.atherosclerosis.2017.04.002CrossrefMedlineGoogle Scholar eLetters(0)eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetails September 26, 2023Vol 148, Issue 13 Advertisement Article InformationMetrics © 2023 American Heart Association, Inc.https://doi.org/10.1161/CIRCULATIONAHA.123.066276PMID: 37747952 Originally publishedSeptember 25, 2023 PDF download Advertisement SubjectsCADASILComputerized Tomography (CT)Ethics and Policy